Lexaria Bioscience (LEXX) Gross Profit (2017 - 2026)
Lexaria Bioscience (LEXX) posted Gross Profit of $20,000 for fiscal Q2 2026 (quarter ended Feb 28, 2026), down 88.5% from $174,000 a year earlier.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Gross Profit (2017 - 2026) Analysis & Trends
For FY2025 (ended Aug 31, 2025), Lexaria Bioscience's Gross Profit came in at $703,203, up 53.1% from FY2024.
- Annual Gross Profit has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 26.7% (FY2020 to FY2025).
- In prior fiscal years, Lexaria Bioscience's Gross Profit was $459,456 in FY2024 (+136.0%), $194,708 in FY2023 (+6.1%), $183,556 in FY2022 (-66.5%) and $547,392 in FY2021 (+154.1%).
- The fiscal Q2 2026 figure stands as the lowest quarterly Gross Profit since fiscal Q2 2023.
- On a year-over-year basis, Gross Profit increased in six of the last seven quarters, with growth averaging 53.2%.
- The strongest year-over-year quarter for Gross Profit in the past five years was fiscal Q1 2023, with growth of 886.0%; the weakest was fiscal Q1 2022, with a decline of 96.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Lexaria Bioscience | 3.04 Mn | -12.61 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Feb 28, 2026 | 20,000.00 |
| Aug 31, 2025 | 174,000.00 |
| May 31, 2025 | 174,000.00 |
| Feb 28, 2025 | 174,000.00 |
| Nov 30, 2024 | 181,203.00 |
| Aug 31, 2024 | 84,000.00 |
| May 31, 2024 | 84,000.00 |
| Feb 29, 2024 | 145,000.00 |
| Nov 30, 2023 | 146,456.00 |
| Aug 31, 2023 | 30,741.00 |
| May 31, 2023 | 64,960.00 |
| Feb 28, 2023 | 17,067.00 |
| Nov 30, 2022 | 81,940.00 |
| Aug 31, 2022 | 69,901.00 |
| May 31, 2022 | 81,082.00 |
| Feb 28, 2022 | 24,263.00 |
| Nov 30, 2021 | 8,310.00 |
| Aug 31, 2021 | 10,712.00 |
| May 31, 2021 | 144,066.00 |
| Feb 28, 2021 | 161,436.00 |
API Access
Lexaria Bioscience Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();